FANCY metabolomics

In the January Nature Biotechnology, Raamsdonk et al. find that, even when mutation of a gene causes no obvious phenotype, metabolite profiling can still give clues to gene function (Nat Biotechnol 2001, 19:45-50). Their test case involves two yeast strains deleted for either one of the two redundant genes for 6-phosphofructo-2-kinase (6-PF-2-K). These deletion strains fail to show a growth defect, even in chemostat competition experiments, but an analysis of specific metabolites clearly sets th

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the January Nature Biotechnology, Raamsdonk et al. find that, even when mutation of a gene causes no obvious phenotype, metabolite profiling can still give clues to gene function (Nat Biotechnol 2001, 19:45-50). Their test case involves two yeast strains deleted for either one of the two redundant genes for 6-phosphofructo-2-kinase (6-PF-2-K). These deletion strains fail to show a growth defect, even in chemostat competition experiments, but an analysis of specific metabolites clearly sets them apart from wild-type yeast. Raamsdonk et al. then test a more general method, in which the extracts from the two deletion strains and several other metabolic mutants are analyzed by 1H-NMR spectroscopy. Even without identifying the individual metabolites whose concentrations have changed, the two 6-PF-2-K mutants can be clustered together based on the similar changes in particular peaks. This method, dubbed functional analysis by co-responses in yeast (FANCY), is now being applied to a collection ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies